BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32665142)

  • 1. How long should follow-up be continued after R0 resection of perihilar cholangiocarcinoma?
    Nakahashi K; Ebata T; Yokoyama Y; Igami T; Mizuno T; Yamaguchi J; Onoe S; Watanabe N; Nagino M
    Surgery; 2020 Oct; 168(4):617-624. PubMed ID: 32665142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach.
    Komaya K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    Surgery; 2018 Apr; 163(4):732-738. PubMed ID: 29336813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.
    Sallinen V; Sirén J; Mäkisalo H; Lehtimäki TE; Lantto E; Kokkola A; Nordin A
    Scand J Surg; 2020 Sep; 109(3):219-227. PubMed ID: 30791825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.
    Higuchi R; Yazawa T; Uemura S; Izumo W; Furukawa T; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2017 Aug; 24(8):456-465. PubMed ID: 28547855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection.
    Groot Koerkamp B; Wiggers JK; Allen PJ; Besselink MG; Blumgart LH; Busch OR; Coelen RJ; D'Angelica MI; DeMatteo RP; Gouma DJ; Kingham TP; Jarnagin WR; van Gulik TM
    J Am Coll Surg; 2015 Dec; 221(6):1041-9. PubMed ID: 26454735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of additional resection of a margin-positive distal bile duct in perihilar cholangiocarcinoma.
    Otsuka S; Ebata T; Yokoyama Y; Mizuno T; Tsukahara T; Shimoyama Y; Ando M; Nagino M
    Br J Surg; 2019 May; 106(6):774-782. PubMed ID: 30889275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery for perihilar cholangiocarcinoma from a viewpoint of age: Is it beneficial to octogenarians in an aging society?
    Akashi K; Ebata T; Mizuno T; Yokoyama Y; Igami T; Yamaguchi J; Onoe S; Nagino M
    Surgery; 2018 Nov; 164(5):1023-1029. PubMed ID: 30082134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perihilar cholangiocarcinoma: A different concept for radical resection.
    Kovalenko YA; Zharikov YO; Konchina NA; Gurmikov BN; Marinova LA; Zhao AV
    Surg Oncol; 2020 Jun; 33():270-275. PubMed ID: 32561092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant hepatic artery resection for advanced perihilar cholangiocarcinoma: a case-control study with propensity score matching.
    Noji T; Tsuchikawa T; Okamura K; Tanaka K; Nakanishi Y; Asano T; Nakamura T; Shichinohe T; Hirano S
    J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):442-8. PubMed ID: 27207604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
    Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
    Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections.
    Nagino M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Takahashi Y; Nimura Y
    Ann Surg; 2013 Jul; 258(1):129-40. PubMed ID: 23059502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: A propensity score matching analysis of resectable perihilar cholangiocarcinoma.
    Komaya K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    Surgery; 2017 Feb; 161(2):394-404. PubMed ID: 27712872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical Outcomes for Perihilar Cholangiocarcinoma with Vascular Invasion.
    Higuchi R; Yazawa T; Uemura S; Izumo W; Ota T; Kiyohara K; Furukawa T; Egawa H; Yamamoto M
    J Gastrointest Surg; 2019 Jul; 23(7):1443-1453. PubMed ID: 30203230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence after resection with curative intent for distal cholangiocarcinoma.
    Komaya K; Ebata T; Shirai K; Ohira S; Morofuji N; Akutagawa A; Yamaguchi R; Nagino M;
    Br J Surg; 2017 Mar; 104(4):426-433. PubMed ID: 28138968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
    Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
    Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors of early recurrence after R0 resection of hilar cholangiocarcinoma: A single institution experience in China.
    Hu HJ; Jin YW; Shrestha A; Ma WJ; Wang JK; Liu F; Zhu YY; Zhou RX; Regmi P; Cheng NS; Li FY
    Cancer Med; 2019 Apr; 8(4):1567-1575. PubMed ID: 30868740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical resection for Bismuth type IV perihilar cholangiocarcinoma.
    Ebata T; Mizuno T; Yokoyama Y; Igami T; Sugawara G; Nagino M
    Br J Surg; 2018 Jun; 105(7):829-838. PubMed ID: 28488733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Klatskin tumor: long-term survival following surgery].
    Juntermanns B; Fingas CD; Sotiropoulos GC; Jaradat D; Dechêne A; Reis H; Kasper S; Paul A; Kaiser GM
    Chirurg; 2016 Jun; 87(6):514-9. PubMed ID: 27090415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High tumor budding is a strong predictor of poor prognosis in the resected perihilar cholangiocarcinoma patients regardless of neoadjuvant therapy, showing survival similar to those without resection.
    Ito T; Kuriyama N; Kozuka Y; Komatsubara H; Ichikawa K; Noguchi D; Hayasaki A; Fujii T; Iizawa Y; Kato H; Tanemura A; Murata Y; Kishiwada M; Mizuno S; Usui M; Sakurai H; Isaji S
    BMC Cancer; 2020 Mar; 20(1):209. PubMed ID: 32164621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.